Scientific Program
Wed
Thu
Fri
Sat
Wednesday, May 7, 2025
Breast Cancer
Presidential Lecture
New Strategies for the Treatment of ER+/HER2- Endocrine-resistant Breast Cancer
Live Surgery
from 2 operating rooms
- Total Breast Reconstruction With AFT
- Conversion From Implant to AFT
- Various Techniques of BCS and SNB
- Gender-affirming Breast Surgery
- Other Breast Surgeries
Breast Cancer Symposium
Presidential Lecture
Role of Surgery in Breast Cancer Treatment
The Most Relevant Clinical Trials
European Perspective, Global Perspective
Lectures and Discussions
- Invasive Lobular Carcinoma (ILC): Translational Data
- Invasive Lobular Carcinoma (ILC): Clinical Data
- Endocrine Resistance: Translational Data
- The Role of Germline Pathogenic Mutations and Endocrine Sensitivity
- Germline Mutations: Digital Tools for Pathologists and Physicians
- TNBC: Identifying New Biomarkers for Treatment Escalation and De-escalation
Breast Cancer Symposium
Please remark: On Thursday, there will be more lectures in the parallel session BREAST CANCER II.
CMC Crash Course
Biomarker in Targeted Therapies and Management of Toxicity (ADCs) in Endometrial, Ovarian, and Cervical Cancer
CMC Master Course
Surgical and Topographic Anatomy in Ovarian Cancer and Surgical Complication Management in Gynecological Oncology
Thursday, May 8, 2025
Cervical, Endometrial Cancer (and other solid tumors)
Video Session – Beyond the Standards: Tackling the Toughest Complex Cases
Videos, Cases, Discussion, Interaction
- Liver, Lungs, Brain, Stroma, Sarcoma, Vessels – Surgery
- Complication Management: Urological and Thrombosis Complications
Scientific Highlight of the Year
Exclusive Charité-Mayo Data
Cervical/Endometrial Cancer Symposium
Cervical Cancer
Presidential Lecture
Revolution in Cervical Cancer Management, Radical Hysterectomy, Simple Hysterectomy, or Cone Biopsy in Early Stage
The Most Relevant Clinical Trials
ENGOT, GOG and more … – 10 Minutes Around the World
Hottest Debates in Clinical Routine and Research
Primary Local Advanced Cervical Cancer
- Neoadjuvant Chemotherapy
- Primary Radio-Immuno-Chemotherapy
- Primary Surgery: When, How, When Not?
- Panel Discussion: What is the Best Therapy Algorithm?
Endometrial Cancer
Presidential Lecture
Endometrial Cancer Management: Options and Limits to Substitute Chemotherapy?
The Most Relevant Clinical Trials
ENGOT, GOG and more … – 10 Minutes Around the World
Hottest Debates in Clinical Routine and Research
Primary Local Advanced Cervical Cancer
- Primary Chemo-Immunotherapy Plus/Minus PARP Inhibitor
- What are the Predictive Markers for Response to PARP?
- What is the Best Medical Therapy in the Relapse Setting? Endocrine, Immuno after Immuno, Chemo after Chemo, PARP after PARP, Role of ADC
- ITC in Endometrial Cancer
- Panel Discussion: What is the Best Therapy Algorithm?
Breast Cancer II
- Surgical Aspects Under TNBC
- BCS vs. ME; R0 vs. R1 Resektion
- Free Flap or AFT in Breast Reconstruction
- Implant or AFT in Breast Reconstruction
- Implant Infection: How to Avoid and to Treat
- Risk-reducing Surgery: How to Avoid Pitfalls
- PROs: How to Bring Them into Clinical Practice
- Panel Discussions
- Video Session: Breast Surgery
CMC Master Course I
How to Avoid and How to Solve Problems in Breast Surgeries
CMC Master Course II
Basics of Breast Reconstruction: Implant, Flaps, AFT
Friday, May 9, 2025
Ovarian Cancer
Live Surgery
from 3 operating rooms
- En-bloc Resection
- Peritonectomy
- Nerve-sparing Techniques
- Lymph Node Dissection
- ICG techniques
- Perioperative Management
The Most Challenging Case of the Year
Scientific Highlight of the Year
Exclusive Charité-Mayo Data
Ovarian Cancer Symposium
Presidential Lecture
Primary Surgery or Interval Surgery – What is the Current Evidence?
The Most Relevant Clinical Trials
ENGOT, GOG and more … – 10 Minutes Around the World
Hottest Debates in Clinical Routine and Research
- Maintenance Therapy: But What?
- BRCA/HRD-adjusted Surgery in Primary OC?
- What is the Best Therapy in the HRD Group?
- Panel Discussion: What is the Best Therapy Algorithm?
Debate
Relapsed Ovarian Cancer: Salvage Surgery or Neoadjuvant Therapy?
- PRO Surgery
- PRO Neoadjuvant
Platinum or Chemoresistance?
Time to Change the Definition and the Treatment Algorithm
- ADCs
- Rechallenge of Previous Therapy
- Chemotherapy-free Approaches
- Best Supportive Care Only!
- Palliative Surgery
- Discussion
CMC Master Course
Prerehabilitation, Fast Track, ERAS, Minimal-invasive Complication Management
Saturday, May 10, 2025
Cross talk and more…
Presidential Lecture
How We Can Improve Women’s Health
Cardiovascular Diseases
Screening for Cardiovascular Diseases in Women
Biomarkers
Biomarkers in Targeted Therapies: Yesterday, Today, Tomorrow
Guidelines
Guidelines in Women’s Cancer: Global Implications (FIGO)
Learning Across the Diseases
Endocrine Therapy: What is the Code in Breast Cancer, What in Gynecological Malignancies?
- Gynecological Cancer
- Breast Cancer
- Urological Cancer
PARP Inhibitors: What is the Code in Gynecologcial Malignancies, What in Breast Cancer, What in Other Solid Tumors? And Who are the Best Candidates?
- Gynecological Cancer
- Breast Cancer
- Pancreatic Cancer
Checkpoint Therapy: What is the Code in Gynecologcial Malignancies, What in Breast Cancer, What in Other Solid Tumors?
- Gynecological Cancer
- Breast Cancer
- Liver Cancer
ADCs: What is the Code in Gynecologcial Malignancies, What in Breast Cancer, What in Other Solid Tumors?
- Gynecological Cancer
- Breast Cancer
- Other Solid Tumors
Artificial Intelligence
AI for for Tailoring of Targeted Therapies: Where Are We?
Poster Session
- Poster Exhibition and Presentation
- Discussion of the Best Posters
- Poster Award Ceremony
Symposium
CMC Cadaver Course
Gynecology
